Efficacy of CPP-ACP and CPP-ACPF for Prevention and Remineralization of White Spot Lesions in Orthodontic Patients: a Systematic Review of Randomized Controlled Clinical Trials
- PMID: 31762578
- PMCID: PMC6853720
- DOI: 10.5455/aim.2019.27.199-204
Efficacy of CPP-ACP and CPP-ACPF for Prevention and Remineralization of White Spot Lesions in Orthodontic Patients: a Systematic Review of Randomized Controlled Clinical Trials
Abstract
Introduction: Enamel subsurface lesions or white spot lesions (WSLs) are commonly found in orthodontic patients with a prevalence of 5% to 97%.
Aim: This systematic review aimed to evaluate the efficacy of casein phosphopeptide amorphous calcium phosphate (CPP-ACP) and casein phosphopeptide amorphous calcium phosphate fluoride (CPP-ACPF) for prevention and remineralization of WSLs in orthodontic patients in human randomized controlled clinical trials (RCTs).
Methods: Relevant articles were retrieved by searching the Web of Science, Scopus, PubMed, and Cochrane Library databases up to November 2018 with no language or date restriction. The collected data included examination method, groups included in each study with number of patients in each group, study design, follow-up period and summary of important findings of each study. The risk of bias of each study was assessed according to the guidelines of the Cochrane Collaboration's tool.
Results: Of 213 articles retrieved, 13 RCTs were included in this systematic review (none of them were included in the meta-analysis). Three articles showed superior efficacy of CPP-ACP for remineralization of WSLs while four studies reported the superior clinical efficacy of CPP-ACPF for this purpose.
Conclusion: Both CPP-ACP and CPP-ACPF can decrease the prevalence and increase the remineralization of WSLs during/after orthodontic treatment.
Keywords: Casein phosphopeptide amorphous calcium phosphate; Casein phosphopeptide amorphous calcium phosphate fluoride; Orthodontics; White spot lesions.
© 2019 Mohammad Moslem Imani, Mohsen Safaei, Aida Afnaniesfandabad, Hedaiat Moradpoor, Masoud Sadeghi, Amin Golshah, Roohollah Sharifi, Hamid Reza Mozaffari.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Barkley RA. New York: Guilford Press; 1998. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment.
-
- Biederman J, Petty CR, Dolan C, Hughes S, Mick E, Monuteaux MC, et al. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychol Med. 2008;38(7):1027–1036. - PubMed
-
- Lahey BB, Pelham WE, Stein MA, Loney J, Trapani C, Nugent K, et al. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37(7):695–702. - PubMed
LinkOut - more resources
Full Text Sources